Cyteir Therapeutics, Inc. (CYT)
Mar 18, 2024 - CYT was delisted (reason: company dissolved)
3.020
0.00 (0.00%)
Last trade price

Cyteir Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Net Income
-46.06-42.13-20.82-15.04
Depreciation & Amortization
1.380.480.350.22
Share-Based Compensation
4.683.470.470.25
Other Operating Activities
-2.532.151.47-2.98
Operating Cash Flow
-42.53-36.03-18.54-17.56
Capital Expenditures
-0.31-1.19-0.85-0.13
Investing Cash Flow
-0.31-1.19-0.85-0.13
Share Issuance / Repurchase
0.24136.351.430.27
Other Financing Activities
-79.66-36.62
Financing Cash Flow
0.24216.011.4336.89
Net Cash Flow
-42.6178.79-17.9619.2
Free Cash Flow
-42.84-37.22-19.39-17.69
Free Cash Flow Per Share
-1.22-1.91-12.66-4.02
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).